ABBV:CA

ABBV ABBV:CA ARCT Biotechnology Terry Chrisomalis Uncategorized

Arcturus Therapeutics: Downgrading To “Hold” As CF Program Shifts Population Focus

Mar 6, 2026

ABBV ABBV:CA Biotechnology DAWN IPSEF IPSEY JAZZ LLY LLY:CA Terry Chrisomalis Uncategorized WHWK ZLLY:CA

Day One Biopharmaceuticals: ‘Strong Buy,’ Several 2026 Milestones In Play Plus OJEMDA Growth

Mar 5, 2026

ABBV ABBV:CA Biotechnology MLTX MRK MRK:CA Terry Chrisomalis Uncategorized

MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal

Feb 24, 2026